Russell Investments Group, Ltd.
Position in SNDX — Syndax Pharmaceuticals Inc
CIK 1692234
Seattle, WA
Position in SNDX
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$2,951,360
+$580,510 QoQ
Shares Held
135,012
+33.0% QoQ
Ownership
0.151%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#85
of 242 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority
Sole 76%
Shared 0%
None 24%
Common Shares in SNDX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Russell Investments Group, Ltd. holds $1,494,413,888 across 308 Biotechnology names. SNDX ranks #71 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
336,990 | $167,393,033 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
230,151 | $143,508,345 | |
| 3 | RPRX |
Royalty Pharma plc
|
1,694,250 | $94,996,587 | |
| 4 | INCY |
Incyte Corp
|
425,616 | $48,247,822 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
158,228 | $47,631,369 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
783,148 | $44,811,725 | |
| 7 | LGND |
Ligand Pharmaceuticals Inc
|
120,304 | $38,026,888 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
418,025 | $34,098,295 |
All Filings in SNDX
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,951,360 | 135,012 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $2,370,850 | 101,492 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $1,883,313 | 89,639 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $1,223,690 | 79,538 | Shares | Other | 2025-11-13 | |
| 2025-06-30 | $1,181,468 | 126,158 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $1,444,874 | 117,613 | Shares | Other | 2025-05-13 | |
| 2024-12-31 | $383,670 | 29,022 | Shares | Other | 2025-02-13 | |
| 2024-09-30 | $260,143 | 13,514 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $272,699 | 13,283 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $247,805 | 10,412 | Shares | Defined | 2024-05-08 | |
| 2023-12-31 | $369,228 | 17,086 | Shares | Defined | 2024-02-05 | |
| 2023-09-30 | $272,946 | 18,798 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $177,905 | 8,500 | Shares | Defined | 2023-08-10 | |
| 2022-12-31 | $1,007,691 | 39,595 | Shares | Defined | 2023-02-08 | |
| 2021-06-30 | $26,012 | 1,515 | Shares | Defined | 2021-08-04 | |
| 2021-03-31 | $1,433,319 | 64,102 | Shares | Defined | 2021-05-10 | |
| 2020-12-31 | $2,374,986 | 106,789 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $1,845,530 | 125,036 | Shares | Defined | 2020-11-09 | |
| 2020-06-30 | $1,543,087 | 104,122 | Shares | Defined | 2020-08-05 | |
| 2020-03-31 | $1,474,904 | 134,449 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||